Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3093 |
|
Actual shortage: | 247 (8%) | |
Anticipated shortage: | 14 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2823 (91%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-METOPROLOL (TYPE L) | 100MG | TABLET | Resolved | 2020-12-28 | 2021-02-09 | 130716 |
APO-RAMIPRIL | 10MG | CAPSULE | Resolved | 2020-12-28 | 2021-01-26 | 130719 |
APO-RAMIPRIL | 5MG | CAPSULE | Resolved | 2020-12-28 | 2021-02-11 | 130722 |
APO-TIMOP | 0.5% | SOLUTION | Resolved | 2021-01-04 | 2021-12-13 | 130810 |
APO-CELECOXIB | 200MG | CAPSULE | Resolved | 2021-01-08 | 2021-02-10 | 131142 |
APO-DASATINIB | 50MG | TABLET | Resolved | 2021-01-08 | 2021-03-17 | 131145 |
APO-DEFERASIROX (TYPE J) | 180MG | TABLET | Resolved | 2021-01-08 | 2021-01-20 | 131148 |
APO-DEFERASIROX (TYPE J) | 90MG | TABLET | Resolved | 2021-01-08 | 2021-01-20 | 131151 |
APO-DIVALPROEX | 250MG | TABLET (ENTERIC-COATED) | Resolved | 2021-01-08 | 2021-01-12 | 131154 |
APO-ESCITALOPRAM | 20MG | TABLET | Resolved | 2021-01-08 | 2021-01-26 | 131157 |
APO-FLECAINIDE | 50MG | TABLET | Resolved | 2021-01-08 | 2021-01-20 | 131160 |
APO-HYDROMORPHONE | 8MG | TABLET | Resolved | 2021-01-08 | 2021-03-01 | 131163 |
APO-RAMIPRIL | 2.5MG | CAPSULE | Resolved | 2021-01-08 | 2021-02-09 | 131166 |
APO-RAMIPRIL | 5MG | CAPSULE | Resolved | 2021-01-08 | 2021-01-20 | 131176 |
APO-ALFUZOSIN | 10MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-01-18 | 2021-01-20 | 131809 |
APO-ATOMOXETINE | 10MG | CAPSULE | Resolved | 2021-01-18 | 2021-03-15 | 131812 |
APO-CELECOXIB | 100MG | CAPSULE | Resolved | 2021-01-18 | 2021-02-09 | 131815 |
APO-CITALOPRAM | 40MG | TABLET | Resolved | 2021-01-18 | 2021-03-09 | 131870 |
APO-LEVETIRACETAM | 750MG | TABLET | Resolved | 2021-01-18 | 2021-02-26 | 131875 |
APO-METHYLPHENIDATE SR | 20MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-01-18 | 2021-02-10 | 131880 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO PREDNISONE TAB 1MG USP | 1MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1056 |
APO-DILTIAZ TZ | 120MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2017-03-13 | 2017-03-13 | 1064 |
APO-DILTIAZ TZ | 180MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2017-03-13 | 2017-03-13 | 1069 |
APO-DILTIAZ TZ | 240MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2017-03-13 | 2017-03-13 | 1072 |
APO-DILTIAZ TZ | 300MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2017-03-13 | 2017-03-13 | 1075 |
APO-DILTIAZ TZ | 360MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2017-03-13 | 2017-03-13 | 1078 |
APO-HALOPERIDOL TAB 2MG | 2MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1084 |
APO-HALOPERIDOL TAB 5MG | 5MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1087 |
APO-LISINOPRIL/HCTZ | 12.5MG 20MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1090 |
APO-LISINOPRIL/HCTZ | 12.5MG 10MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1093 |
APO-LISINOPRIL/HCTZ | 25MG 20MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1096 |
APO-METOCLOP TAB 10MG | 10MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1101 |
APO-METOCLOP TAB 5MG | 5mg | tablet | Discontinued | 2017-03-13 | 2017-03-13 | 1105 |
APO-NITRAZEPAM | 5MG | TABLET | Discontinued | 2017-03-13 | 2018-12-07 | 1110 |
APO-NITRAZEPAM | 10MG | TABLET | Discontinued | 2017-03-13 | 2018-12-07 | 1117 |
APO-NIZATIDINE | 150MG | CAPSULE | Discontinued | 2017-03-13 | 2017-03-13 | 1127 |
APO-NIZATIDINE | 300MG | CAPSULE | Discontinued | 2017-03-13 | 2017-03-13 | 1135 |
APO-NORTRIPTYLINE | 10MG | CAPSULE | Discontinued | 2017-03-13 | 2017-03-13 | 1145 |
APO-NORTRIPTYLINE | 25MG | CAPSULE | Discontinued | 2017-03-13 | 2017-03-13 | 1155 |
APO-PROPRANOLOL | 20MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1163 |